首页> 外文期刊>Journal of managed care pharmacy : >FMCP RESEARCH SYMPOSIUM SURVEY RESULTS
【24h】

FMCP RESEARCH SYMPOSIUM SURVEY RESULTS

机译:FMCP研究研讨会调查结果

获取原文
获取原文并翻译 | 示例
       

摘要

Before the Research Symposium in Atlanta on October 18, 2011, FMCP leadership and the AMCP board were asked to complete an on-line survey. The questionnaire sought comments on issues related to managed care pharmacy research. This executive summary describes the questions asked and common responses.HOW WILL COMPARATIVE-EFFECTIVENESS RESEARCH (CER) INFORM MEDICAL AND PHARAAACY BENEFIT COVERAGE DECISIONS?:Although few respondents believe that CER plays an active role today (because of a paucity of good data), most envision that it will be beneficial in a number of areas, as more studies that meet the intent of CER are completed. One participant summed up the voice of the majority, saying "CER will provide managed care decision-makers with yet another important tool to more effectively drive formulary positioning, coverage guidelines, and promotion of scientifically-based best practice." The term "informed formulary decision making" was oft repeated.
机译:在2011年10月18日于亚特兰大举行的研究研讨会之前,要求FMCP领导层和AMCP理事会完成在线调查。该调查表征求有关管理式护理药房研究相关问题的意见。本执行摘要描述了所提出的问题和常见的回答。比较效能研究(CER)如何告知医疗和保证受益范围决定?:尽管很少有受访者认为CER在今天起着积极的作用(由于缺乏良好的数据),大多数人认为,随着更多符合CER意图的研究完成,它将在许多领域都将是有益的。一位与会者总结了多数人的声音,他说:“ CER将为管理式护理决策者提供另一种重要工具,以更有效地推动处方药的定位,覆盖范围指南以及基于科学的最佳实践的推广。”经常重复“明智的配方决策”一词。

著录项

  • 来源
    《Journal of managed care pharmacy :》 |2011年第meetingproceedings期|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

  • 入库时间 2022-08-19 01:56:11

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号